Visiba is pleased to announce the appointment of Dr Annabelle Painter as new Chief Medical Officer. As Visiba continue to develop their AI-enabled triage solution, the clinical perspective is critical to ensuring that the solution is clinically safe and meets the needs of practising clinicians.
Annabelle’s career spans digital product development, AI evaluation, public policy, clinical medicine and academia. Her roles have included being Clinical AI & Workforce Fellow at the NHS AI Lab, AI Clinician at Babylon Health and Honorary Fellow at Imperial College London. Annabelle continues her clinical work in General Practice and contributes significantly to the Royal Society of Medicine’s Digital Health Council, hosting their popular Digital Health podcast series where she interviews experts on key digital health topics. Dr Annabelle Painter, Chief Medical Officer (CMO) at Visiba comments:
"I was first attracted to Visiba by their focus on creating a solution that meets the needs of the healthcare system whilst prioritising clinician needs and patient safety. Combining my role as CMO with ongoing clinical work will enable me to ensure that we continue to develop the solution with the clinician and patient perspective front of mind.”
Annabelle is a passionate advocate for using technology to improve healthcare delivery and patient outcomes. In her role at Visiba Annabelle will be an essential part of the senior management team, reporting directly to the CEO. Her extensive experience and visionary leadership are expected to be invaluable as Visiba embark on an exciting phase of international growth and innovation in AI-enabled triage. Annabelle’s appointment underscores Visiba’s commitment to transforming healthcare through cutting-edge technology and maintaining the highest standards of medical excellence.
Johan Gustafsson, Chief Executive Officer at Visiba says:
"We aim to deliver a market-leading AI-enabled triage solution that enables healthcare providers to better meet the ever-growing needs of patients. Ensuring the clinical voice is heard and understood is a vital part of our growth and ability to deliver a clinically safe solution.
“Since Annabelle started working with us almost 12 months ago, she has continued to impress us with her focus on quality and patient safety. Annabelle brings a unique blend of clinical, technical and AI expertise so we’re thrilled that she has agreed to step into the CMO role with us.”
